Sortiert nach Autor

Publikationen - sortiert nach Autor

• Milenkovic I, Bartova L, Papageorgiou K, Kasper S, Traub-Weidinger T, Winkler D (2021) Case Report: Bupropion Reduces the [123I]FP-CIT Binding to Striatal Dopamine Transporter Front Psychiatry, 12: 631357
  | Weblink |

• Shiyam Sundar L, Iommi D, Muzik O, Chalampalakis Z, Klebermass E, Hienert M, Rischka L, Lanzenberger R, Hahn A, Pataraia E, Traub-Weidinger T, Hummel J, Beyer T (2020) Conditional Generative Adversarial Networks Aided Motion Correction of Dynamic 18F-FDG PET Brain Studies J Nucl Med, 62 (6): 871-879

• Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hartmann A, Hacker M, Rujescu D, Kasper S, Lanzenberger R (2019) Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET Mol Psychiatry,
  | Weblink |

• James G, Baldinger-Melich P, Philippe C, Kranz G, Vanicek T, Hahn A, Gryglewski G, Hienert M, Spies M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R (2017) Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression Front Hum Neurosci, 11: 48
  | Weblink |
• Gryglewski G, Rischka L, Philippe C, Hahn A, James G, Klebermass E, Hienert M, Silberbauer L, Vanicek T, Kautzky A, Berroterán-Infante N, Nics L, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R (2017) Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion Neuroimage, 149: 23-32
  | Weblink |
• Komorowski A, James GM, Philippe C, Gryglewski G, Bauer A, Hienert M, Spies M, Kautzky A, Vanicek T, Hahn A, Traub-Weidinger T, Winkler D, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger (2017) Association of protein distribution and gene expression revealed by PET and post-mortem quantification in the serotonergic system of the human brain Cereb. Cortex, 27: 117-130
  | Weblink |
• Vanicek T, Kutzelnigg A, Philippe C, Sigurdardottir H, James G, Hahn A, Kranz G, Höflich A, Kautzky A, Traub-Weidinger T, Hacker M, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R (2017) Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET Human Brain Mapping, 38 (2): 792-802
  | Weblink |

• Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Rujescu D, Kasper S, Lanzenberger R (2016) Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET Human Brain Mapping, 37 (3): 884-895
  | Weblink |

• Kraemmer J, Kovacs G, Perju-Dumbrava L, Pirker S, Traub-Weidinger T, Pirker W (2014) Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts Movement Disorders, 29 (14): 1767-1773

• Pirker S, Perju-Dumbrava L, Kovacs G, Traub-Weidinger T, Asenbaum S, Pirker W (2013) Dopamine D2 receptor SPECT in corticobasal syndrome and autopsy-confirmed corticobasal degeneration Parkinsonism & Related Disorders, 19 (2): 222-226